Home » Airways Disorders NetWork

Airways Disorders NetWork

February 19, 2010
FDA Announcement on LABAs

On February 18, 2010, the ACCP participated in a teleconference hosted by the FDA to explain new information about long-acting beta-agonists (LABAs). This new safety information for consumers and health-care professionals has been posted on the FDA Web site.

February 01, 2010
Follow-Up to the October 2008 Updated Early Communication About an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler)
This is a follow-up to previous Early Communications issued in 2008 by the US Food and Drug Administration (FDA) describing a potential increase in the risk of stroke, heart attack, or death from a cardiovascular cause related to the use of tiotropium, which is marketed as Spiriva HandiHaler.
January 01, 2010
A Man With A History of Vasculitis and Wheezing

A 27-year-old man was diagnosed with Wegener granulomatosis (WG) and treated with corticosteroids and cytotoxic agents.

July 01, 2009
Airways Disorders NetWork Online Puzzler
The patient is a 57-year-old African-American man with a history of well-controlled asthma treated with mometasone. He had a positive PPD test in the 1970s and presented to the pulmonary clinic for evaluation of chronic, progressive cough and abnormal chest imaging. The patient’s cough began approximately 2 months ago. His cough was initially nonproductive but progressed to become productive with thick, tenacious yellow-green sputum. He denied any weight loss, fevers, chills, or hemoptysis.
January 15, 2009
COPD Literature Review

Dr. Brahman Reviews COPD Literature of 2008

November 01, 2008
NetWork Special Presentations from CHEST 2008
All presentations are in read-only PDF format. Printing is restricted. To download a presentation to your computer, click on the presentation title.
January 16, 2008
Important differences between HFA and CFC inhalers
The older chlorofluorocarbon (CFC)-containing inhalers will be completely off the market at the end of 2008, but they already are getting harder to find. Hydroflouroalkane (HFA) inhalers are as effective as CFC inhalers and have the same rate of side effects. However, if they are not used properly, patients will not get the adequate dose. As with older inhalers, it is the technique of using the inhaler that may lead to poor results, not the type of propellant.
January 01, 2008
Airways Disorders Literature Recommendations
Literature recommendations from the Airways NetWork.
November 01, 2007
NetWork Special Presentations from CHEST 2007
All presentations are in read-only PDF format. Printing is restricted. To download a presentation to your computer, click on the presentation title.
January 01, 2006
Patient Instructions for Inhaled Devices In English and Spanish
These step-by step instructions are for patients and physicians. Select and print the appropriate sheets.
January 01, 2004
Living Well With COPD: Chronic Bronchitis and Emphysema

For most people, living with chronic obstructive pulmonary disease (COPD) is not easy.